936344-74-0 Usage
Uses
Used in Medicinal Chemistry:
3-Ethynyl-5-fluoropyridin-2-amine is utilized as a building block for the synthesis of various pharmaceutical compounds. Its distinctive structure allows it to be a key component in the creation of new medications.
Used in Drug Discovery:
As a compound with potential biological activities, such as enzyme inhibition or receptor binding, 3-Ethynyl-5-fluoropyridin-2-amine serves as a valuable tool in the identification and development of novel drugs.
Used in Organic Synthesis:
3-Ethynyl-5-fluoropyridin-2-amine is an important intermediate in organic synthesis, where its specific structure and properties are harnessed to facilitate the creation of complex organic molecules.
Used in Pharmaceutical Research:
The unique structure and properties of 3-Ethynyl-5-fluoropyridin-2-amine make it a valuable tool for pharmaceutical research, aiding scientists in understanding and developing new therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 936344-74-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,6,3,4 and 4 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 936344-74:
(8*9)+(7*3)+(6*6)+(5*3)+(4*4)+(3*4)+(2*7)+(1*4)=190
190 % 10 = 0
So 936344-74-0 is a valid CAS Registry Number.
936344-74-0Relevant articles and documents
METHODS OF PREPARING INHIBITORS OF INFLUENZA VIRUSES REPLICATION
-
Paragraph 0315-0318, (2015/06/03)
A method of preparing Compound (1) or a pharmaceutically acceptable salt thereof: comprises: (a) reacting Compound (X): a pharmaceutically acceptable salt thereof with Compound (Y): in the presence of a palladium catalyst and a carbonate or phosphate base
SELECTIVE AZOLE PDE10A INHIBITOR COMPOUNDS
-
Page/Page column 105, (2010/11/29)
The invention pertains to heteroaromatic compounds of the formula I, as defined herein, that serve as effective phosphodiesterase (PDE) inhibitors. In particular, the invention relates to said compounds which are selective inhibitors of PDE10. The invention also relates to pharmaceutical compositions comprising said compounds; and the use of said compounds in a method for treating certain central nervous system (CNS) or other disorders.